# Longitudinal Imaging Biomarkers of Disease Progression in DLB

> **NCT03582488** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Kejal Kantarci** · enrollment: 135 (estimated)

## Conditions studied

- Lewy Body Disease

## Interventions

- **DRUG:** 18F-Flortaucipir

## Key facts

- **NCT ID:** NCT03582488
- **Lead sponsor:** Kejal Kantarci
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-06-25
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582488, "Longitudinal Imaging Biomarkers of Disease Progression in DLB". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT03582488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*